Patent ID: 9676848
Date: 2017-06-13
CPC Classifications: A61K,A61P,C07K

Claim:
1. A pen-injector containing a liquid pharmaceutical formulation comprising an effective amount of an isolated anti-IL-12 antibody having a heavy chain variable region and a light chain variable region, said heavy chain variable region comprising: a heavy chain complementarity determining region 1 (CDR1) comprising the amino acid sequence of SEQ ID NO:1, a heavy chain complementarity determining region 2 (CDR2) comprising the amino acid sequence of SEQ ID NO:2, a heavy chain complementarity determining region 3 (CDR3) comprising the amino acid sequence of SEQ ID NO:3, said light chain variable region comprising: a light chain complementarity determining region 1 (CDR1) comprising the amino acid sequence of SEQ ID NO:4, a light chain complementarity determining region 2 (CDR2) comprising the amino acid sequence of SEQ ID NO:5, and a light chain complementarity determining region 3 (CDR3) comprising the amino acid sequence of SEQ ID NO:6.